SLU-PP-915: dosing and an honest frame
> Updated:
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
SLU-PP-915 is an orally active ERR agonist (an "exercise mimetic") that is taken by mouth in studies; unlike SLU-PP-332 it does not require injection. The figures below are a generalized reference drawn from preclinical work (mice only), not human clinical data.
This is a concise reference to regimens described for adults; it is not an individual prescription.
SLU-PP-915 dosage actually answers a different question than SLU-PP-332's: not vial concentration, but how many oral milligrams per day, since the route of administration here is different.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (oral) | 1 mg per day | Starting dose |
| Titration | 1–2 mg per day | Increase if needed |
| Upper reference in this schedule | up to 2–3 mg per day (may be split into 2 doses) | Maximum in this schedule |
Practical dosing and effect details
In Billon and colleagues' study (Journal of Pharmacology and Experimental Therapeutics, 2025/2026), SLU-PP-915 was given to mice orally, and its effect on running endurance turned out comparable to injectable SLU-PP-332 given intraperitoneally. The authors also showed the effect is stronger combined with exercise training rather than acting on its own. The data come from mice only.
That is exactly why the dosage on this page is expressed in oral milligrams per day (1-3 mg) rather than injection micrograms the way SLU-PP-332's page is: a different route means a different dose unit.
The upper range on this page (2-3 mg) is split into 2 doses for a reason: an oral dose less reliably holds a steady compound level for as long as a subcutaneous one does, so a single large dose is avoided here.
This is reference information for planning a research protocol, not a medical recommendation and not instructions for self-administration.
This reference is research-use material. The information is not medical advice and is not intended for diagnosis, treatment or prevention of disease.